Abstract
The liver is the most common site of metastatic disease, with an estimated 15–25% of colorectal cancer (CRC) patients at the time of diagnosis presenting with synchronous colorectal liver metastases (SCRLM). Patients with synchronous liver metastases presenting at clinical evaluation for resection have increased in number, and dealing with these patients has become extremely frequent in the daily practice of a hepatobiliary center. The best surgical strategy for these patients is a matter of endless debate. The primary-first, the liver-first, and the simultaneous combined approaches should not be mutually exclusive but rather proposed to different types of patients. Surgical strategy should be based on liver and colorectal tumour burden, and on evaluation of surgical risk of planned surgery. The real possibility to obtain prolonged survivals and also cure of these patients is based on the best combination of modern systemic chemotherapy with safe surgery. The early discussion involving dedicated medical oncologist, liver surgeon, colorectal surgeon, radiotherapist in the management of a patient with colorectal cancer and synchronous liver metastases is crucial to best determine the timing and sequence of chemotherapy and surgery, the radiotherapy when indicated, and hence to improve patient outcomes and survival.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lillemoe HA, Vauthey JN. Surgical approach to synchronous colorectal liver metastases: staged, combined, or reverse strategy. Hepatobiliary Surg Nutr. 2020;9(1):25–34.
Adam R, de Gramont A, Figueras J, et al. Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev. 2015;41(9):729–41.
Ignatavicius P, Oberkofler CE, Chapman WC, et al. Choices of therapeutic strategies for colorectal liver metastases among expert liver surgeons: a throw of the dice? Ann Surg. 2020;272(5):715–22.
Mentha G, Majno PE, Andres A, et al. Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary. Br J Surg. 2006;93:872–8.
Padmanabhan C, Nussbaum DP, D’Angelica M. Surgical management of colorectal cancer liver metastases. Surg Oncol Clin N Am. 2021;30(1):1–25.
Adam R, Kitano Y. Multidisciplinary approach of liver metastases from colorectal cancer. Ann Gastroenterol Surg. 2019;3(1):50–6.
Ghiasloo M, Pavlenko D, Verhaeghe M, et al. Surgical treatment of stage IV colorectal cancer with synchronous liver metastases: a systematic review and network meta-analysis. Eur J Surg Oncol. 2020;46(7):1203–13.
van Hooft JE, Veld JV, Arnold D, et al. Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) guideline—update 2020. Endoscopy. 2020;52(5):389–407.
Stewart CL, Warner S, Ito K, et al. Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure? Curr Probl Surg. 2018;55(9):330–79.
Skelton WP 4th, Franke AJ, Iqbal A, et al. Comprehensive literature review of randomized clinical trials examining novel treatment advances in patients with colon cancer. J Gastrointest Oncol. 2020;11(4):790–802.
Shubert CR, Habermann EB, Bergquist JR, et al. A NSQIP review of major morbidity and mortality of synchronous liver resection for colorectal metastasis stratified by extent of liver resection and type of colorectal resection. J Gastrointest Surg. 2015;19(11):1982–94.
American Cancer Society. Colorectal Cancer Facts & Figures 2017–2019. Atlanta, GA: American Cancer Society; 2017. p. 1–40.
Sturesson C, Valdimarsson VT, Blomstrand E, et al. Liver-first strategy for synchronous colorectal liver metastases—an intention-to-treat analysis. HPB (Oxford). 2017;19(1):52–8.
Kopetz S, Chang GJ, Overman MJ, et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol. 2009;27(22):3677–83.
Lim C, Doussot A, Osseis M, et al. Bevacizumab improves survival in patients with synchronous colorectal liver metastases provided the primary tumor is resected first. Clin Transl Oncol. 2018;20(10):1274–9.
Pinson H, Cosyns S, Ceelen WP. The impact of surgical resection of the primary tumor on the development of synchronous colorectal liver metastasis: a systematic review. Acta Chir Belg. 2018;118(4):203–11.
Vallance AE, van der Meulen J, Kuryba A, et al. The timing of liver resection in patients with colorectal cancer and synchronous liver metastases: a population-based study of current practice and survival. Color Dis. 2018;20:486–95.
Valdimarsson VT, Syk I, Lindell G, et al. Outcomes of liver-first strategy and classical strategy for synchronous colorectal liver metastases in Sweden. HPB (Oxford). 2018;20:441–7.
Buchs NC, Ris F, Majno PE, et al. Rectal outcomes after a liver-first treatment of patients with stage IV rectal cancer. Ann Surg Oncol. 2015 Mar;22(3):931–7.
Brouquet A, Mortenson MM, Vauthey JN, et al. Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy? J Am Coll Surg. 2010;210:934–41.
Nierop PMH, Verseveld M, Galjart B, et al. The liver-first approach for locally advanced rectal cancer and synchronous liver metastases. Eur J Surg Oncol. 2019;45(4):591–6.
Båverud Olsson L, Buchli C, et al. Differences in management and outcome for colon and rectal carcinoma with synchronous liver metastases: a population-based cohort study. Color Dis. 2021;23(4):860–7.
Sager O, Dincoglan F, Demiral S, et al. A concise review of pelvic radiation therapy (RT) for rectal cancer with synchronous liver metastases. Int J Surg Oncol. 2019;2019:5239042.
Labori KJ, Guren MG, Brudvik KW, et al. Resection of synchronous liver metastases between radiotherapy and definitive surgery for locally advanced rectal cancer: short-term surgical outcomes, overall survival and recurrence-free survival. Color Dis. 2017;19(8):731–8.
Karoui M, Scatton O. The “short-cut” laparoscopic reverse approach: a novel strategy for synchronous colorectal cancer and liver metastases requiring major or complex procedures? World J Surg. 2019;43(8):2086–9.
D’Hondt M, Lucidi V, Vermeiren K, et al. The interval approach: an adaptation of the liver-first approach to treat synchronous liver metastases from rectal cancer. World J Surg Oncol. 2017;15(1):54.
Abbott AM, Parsons HM, Tuttle TM, et al. Short-term outcomes after combined colon and liver resection for synchronous colon cancer liver metastases: a population study. Ann Surg Oncol. 2013;20:139–47.
Ejaz A, Semenov E, Spolverato G, et al. Synchronous primary colorectal and liver metastasis: impact of operative approach on clinical outcomes and hospital charges. HPB. 2014;16:1117–26.
Yin Z, Liu C, Chen Y, et al. Timing of hepatectomy in resectable synchronous colorectal liver metastases (SCRLM): simultaneous or delayed? Hepatology. 2013;57:2346–57.
Vassiliou I, Arkadopoulos N, Theodosopoulos T, et al. Surgical approaches of resectable synchronous colorectal liver metastases: timing considerations. World J Gastroenterol. 2007;13:1431–4.
Reddy SK, Pawlik TM, Zorzi D, et al. Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. Ann Surg Oncol. 2007;14(12):3481–91.
Martin RC 2nd, Augenstein V, Reuter NP, et al. Simultaneous versus staged resection for synchronous colorectal cancer liver metastases. J Am Coll Surg. 2009;208(5):842–50.
Kaibori M, Iwamoto S, Ishizaki M, et al. Timing of resection for synchronous liver metastases from colorectal cancer. Dig Dis Sci. 2010;55(11):3262–70.
de Haas RJ, Adam R, Wicherts DA, et al. Comparison of simultaneous or delayed liver surgery for limited synchronous colorectal metastases. Br J Surg. 2010;97(8):1279–89.
Luo Y, Wang L, Chen C, et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastases. J Gastrointest Surg. 2010;14(12):1974–80.
Abbott DE, Cantor SB, Hu CY, et al. Optimizing clinical and economic outcomes of surgical therapy for patients with colorectal cancer and synchronous liver metastases. J Am Coll Surg. 2012;215(2):262–70.
Mayo SC, Pulitano C, Marques H, et al. Surgical management of patients with synchronous colorectal liver metastasis: a multicenter international analysis. J Am Coll Surg. 2013;216(4):707–16.
Valdimarsson VT, Syk I, Lindell G, et al. Outcomes of simultaneous resections and classical strategy for synchronous colorectal liver metastases in Sweden: a Nationwide study with special reference to major liver resections. World J Surg. 2020;44(7):2409–17.
Boudjema K, Locher C, Sabbagh C, et al. METASYNC study group. Simultaneous versus delayed resection for initially resectable synchronous colorectal cancer liver metastases: a prospective, open-label, randomized, controlled trial. Ann Surg. 2021;273(1):49–56.
Gavriilidis P, Sutcliffe RP, Hodson J, et al. Simultaneous versus delayed hepatectomy for synchronous colorectal liver metastases: a systematic review and meta-analysis. HPB (Oxford). 2018;20(1):11–9.
Idrees JJ, Bagante F, Gani F, et al. Population level outcomes and costs of single stage colon and liver resection versus conventional two-stage approach for the resection of metastatic colorectal cancer. HPB (Oxford). 2019;21(4):456–64.
Krell RW, D’Angelica MI. Treatment sequencing for simultaneous colorectal liver metastases. J Surg Oncol. 2019;119(5):583–93.
Hsu KF, Yu JC, Chen TW, et al. Experience with reversed L-shaped incision for right hemicolectomy combined with liver resection. World J Surg. 2009;33(12):2679–82.
Kim SH, Kim YK. Upper midline incision for liver resection. HPB (Oxford). 2013;15(4):273–8.
Chang SB, Palavecino M, Wray CJ, et al. Modified Makuuchi incision for foregut procedures. Arch Surg. 2010;145(3):281–4.
Ferretti S, Tranchart H, Buell JF, et al. Laparoscopic simultaneous resection of colorectal primary tumor and liver metastases: results of a multicenter international study. World J Surg. 2015;39(8):2052–60.
Hatwell C, Bretagnol F, Farges O, et al. Laparoscopic resection of colorectal cancer facilitates simultaneous surgery of synchronous liver metastases. Color Dis. 2013;15(1):e21–8.
Ratti F, Catena M, Di Palo S, et al. Laparoscopic approach for primary colorectal cancer improves outcome of patients undergoing combined open hepatic resection for liver metastases. World J Surg. 2015;39(10):2573–82.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Giuliante, F., Ardito, F., De Rose, A.M. (2022). Synchronous Presentation of Primary and Colorectal Liver Metastasis: Classic, Reverse, and Combined. In: Vauthey, JN., Kawaguchi, Y., Adam, R. (eds) Colorectal Liver Metastasis. Springer, Cham. https://doi.org/10.1007/978-3-031-09323-4_20
Download citation
DOI: https://doi.org/10.1007/978-3-031-09323-4_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-09322-7
Online ISBN: 978-3-031-09323-4
eBook Packages: MedicineMedicine (R0)